Yst Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 9.50 Cr
as on 23-10-2024
- Paid Up Capital ₹ 9.50 Cr
as on 23-10-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.50 Cr
as on 23-10-2024
- Satisfied Charges ₹ 2.50 Cr
as on 23-10-2024
- Revenue 7.91%
(FY 2023)
- Profit 36.81%
(FY 2023)
- Ebitda 185.60%
(FY 2023)
- Net Worth 15.27%
(FY 2023)
- Total Assets 99.77%
(FY 2023)
About Yst Life Sciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.50 Cr and a paid-up capital of Rs 9.50 Cr.
The company currently has active open charges totaling ₹12.50 Cr. The company has closed loans amounting to ₹2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Yash Tikekar and Vasant Tikekar serve as directors at the Company.
- CIN/LLPIN
U24304MH2017PTC292660
- Company No.
292660
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Yst Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vasant Tikekar  | Director | 11-Mar-2019 | Current |
| Yash Tikekar | Director | 20-Mar-2017 | Current |
Financial Performance of Yst Life Sciences.
Yst Life Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.91% increase. The company also saw a substantial improvement in profitability, with a 36.81% increase in profit. The company's net worth Soared by an impressive increase of 15.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yst Life Sciences?
In 2023, Yst Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chemical Brothers Enterprises Private LimitedActive 10 years 4 monthsYash Tikekar and Vasant Tikekar are mutual person
Yst Surfactants Private LimitedActive 1 year 5 monthsYash Tikekar and Vasant Tikekar are mutual person
- Vrt Enterprises Private LimitedActive 5 years 3 months
Yash Tikekar and Vasant Tikekar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Oct 2023 | ₹9.50 Cr | Open |
Others Creation Date: 03 Oct 2023 | ₹3.00 Cr | Open |
Canara Bank Creation Date: 16 Feb 2021 | ₹2.50 Cr | Satisfied |
How Many Employees Work at Yst Life Sciences?
Unlock and access historical data on people associated with Yst Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yst Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yst Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
